Hawa Sibo 90cap 120g - Hawa Pharma

HAWA SIBO 90cap 120g from Hawa Pharma for balancing dysbiosis and promoting homeostasis in normal intestinal function.

The gastrointestinal tract is a highly sensitive system, with the functions of digestion, absorption, protection and excretion.

Intestinal imbalances are increasingly common and often overlooked at an early stage. This broad spectrum of enteropathies, characterized by local inflammation, decreased absorption, and increased intestinal permeability, is linked to the development of several chronic conditions. These include autoimmune diseases, fibromyalgia, intestinal dysbiosis, depression, chronic fatigue, intestinal permeability, and SIBO.

The gut microbiota plays an essential role in normal intestinal function and in maintaining human health. A healthy and balanced gut flora is largely responsible for the overall health of the host. SIBO stands for Small Intestinal Bacterial Overgrowth, meaning an excessive growth of bacteria in the small intestine. This disturbance in the gut microbiome is a manifestation of dysbiosis characterized by an abnormal number or a change in the type of enteric bacteria present in the small intestine. In turn, it leads to gastrointestinal symptoms such as diarrhea, constipation, flatulence, cramping, bloating, indigestion, weight loss, and nutritional malabsorption. The overall prevalence is unknown, although it is higher in adults and in the presence of other gastrointestinal tract pathologies, such as irritable bowel syndrome, celiac disease, diverticulitis, gastroparesis, and others.

The potential role of SIBO in irritable bowel syndrome was first proposed approximately two decades ago. Pimentel et al. diagnosed SIBO in 78% of irritable bowel syndrome patients using a lactulose breath test. More recently, in 2020, a meta-analysis involving 3,192 irritable bowel syndrome patients found a 31.0% prevalence of SIBO compared with the control group.

Unlike the large intestine, the concentration of bacteria in the small intestine is reduced. In SIBO, the bacterial population in the small intestine exceeds 105-106 CFU organisms m/L,2 with an increase in several pathogenic organisms, including, but not limited to, Enterococcus, Escherichia coli, and Klebsiella. As a consequence of dysbacteriosis, increased intestinal permeability, dysmotility, chronic inflammation, autoimmunity, decreased absorption, and even altered enteric and central neuronal activity may occur. In contrast to the normal situation, in which digestion and absorption of food are complete before the bolus reaches the bacteria in the colon, in patients with SIBO, the ingested food comes into contact with bacteria in the jejunum and ileum and is fermented to produce gas. Clinical manifestations occur not only due to the presence of excess bacteria, but also due to inflammation caused by the production of enzymes or endotoxins by invading strains, which damage the epithelial cell layer. Symptoms include a combination of abdominal discomfort, pain, distension, flatulence, nausea, constipation, and diarrhea, which vary in frequency, duration, and severity.

Currently, due to increased awareness and understanding, SIBO is frequently considered in the diagnosis of nonspecific and highly prevalent gastrointestinal complaints in Irritable Bowel Syndrome.

As it is a major cause of decreased quality of life and available therapeutic approaches are often not very effective, there is growing interest in the use of Integrative Medicine in the treatment of gastrointestinal disorders.

Hawa Sibo presents itself as a natural alternative to antibiotics, thanks to the synergy of its active ingredients. The kit format contains a jar of L-glutamine powder and a jar of capsules containing medicinal plants with complementary action and high antibacterial, anti-inflammatory, antioxidant, immunomodulatory, and carminative activity.

Medicinal plants are potential modulators of the excessive growth of intestinal bacteria, due to the action of their bioactive principles and because they are free of harmful adverse effects.

The interconnection of all the constituents in the Hawa SIBO formula allows for a comprehensive therapeutic approach, focused on the origin of the symptomatic picture, the remission of symptoms and the normalization of intestinal motility, contributing to reducing excessive bacterial growth, eliminating pathogenic bacteria, repairing damage to the intestinal wall caused by intestinal permeability, reducing pain and inflammation, with improvements in symptoms.



Packaging of 90 capsules + 120g